Shidong Lv
-
- Cancer, Lipids, and Metabolism 3
-
- Epigenetics and DNA Methylation 9
- Cancer-related gene regulation 4
- Ubiquitin and proteasome pathways 3
- Protein Degradation and Inhibitors 2
-
- Prostate Cancer Treatment and Research 8
- Renal cell carcinoma treatment 3
-
- Bladder and Urothelial Cancer Treatments 2
- Co-authors
- Hongyi WangChengyong LeiQiang WeiYongtong ZhuWei WangWenhua HuangShuqiang LiuZhongqiu Liu
- Journals
- The Prostate (2 papers)Asian Journal of Andrology (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Shidong Lv
24 papers receiving 382 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 97
- Molecular Biology 252
- Pulmonary and Respiratory Medicine 111
- Oncology 74
- Cell Biology 28
Countries citing papers authored by Shidong Lv
This map shows the geographic impact of Shidong Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shidong Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shidong Lv more than expected).
Fields of papers citing papers by Shidong Lv
This network shows the impact of papers produced by Shidong Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shidong Lv. The network helps show where Shidong Lv may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shidong Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 11 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 14 | |
| 12 | 2020 | 42 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 20 | |
| 15 | 2019 | 9 | |
| 16 | 2019 | 75 | |
| 17 | 2018 | 19 | |
| 18 | 2018 | 19 | |
| 19 | 2017 | 90 | |
| 20 | [Small RNA interference-mediated ADP-ribosylation factor 6 silencing inhibits proliferation, migration and invasion of human prostate cancer PC-3 cells]. | 2016 | 2 |
About Shidong Lv
Shidong Lv is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 25 papers that have together received 386 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (9 papers), Prostate Cancer Treatment and Research (8 papers), Cancer-related gene regulation (4 papers), Renal cell carcinoma treatment (3 papers), Cancer, Lipids, and Metabolism (3 papers), Ubiquitin and proteasome pathways (3 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Cancer Research (97 citations), Molecular Biology (252 citations) and Pulmonary and Respiratory Medicine (111 citations). Shidong Lv has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Hongyi Wang, Chengyong Lei, Qiang Wei, Yongtong Zhu, Wei Wang, Qiang Wei, Wenhua Huang, Shuqiang Liu, Zhongqiu Liu and Elaine Lai‐Han Leung. Their work appears in journals such as The Prostate, Asian Journal of Andrology, Journal of Pharmacology and Experimental Therapeutics, Cell Death Discovery and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.